14Sep 2022
Loss of GABARAPL1 confers ferroptosis resistance to cancer stem‐like cells in hepatocellular carcinoma

Loss of GABARAPL1 confers ferroptosis resistance to cancer stem‐like cells in hepatocellular carcinoma

Ferroptosis‐related stemness genes (FRSG) were found to be significantly associated with the immunity and prognosis of hepatocellular carcinoma (HCC). An FRSG‐based risk score effectively predicted HCC patient prognosis, and loss of GABARAPL1 conferred ferroptosis resistance of HCC cancer stem‐like cells, while overexpressing it may recover sensitivity.

  • #oncology

Like

Save

Share